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Abstract
Ménière disease (MD) is a chronic illness of
the inner ear that affects a substantial number
of patients every year worldwide. Because of a
dearth of well-controlled studies, the medical
and surgical management of MD remains quite
empirical. The main reason is that it is very dif-
ficult to investigate patients affected with
Certain MD due to the post-mortem criterion
necessary for this diagnostic grade. Although
endolymphatic hydrops (EH) is the worldwide-
accepted mechanism of MD, the causes that
induce it are still not clear. In fact MD has been
correlated mostly to a wide and different distur-
bances ranging from trauma to sleep disorders.
It is nowadays sufficiently demonstrated that
chronic cerebrospinal venous insufficiency
(CCSVI) is very frequent in MD. Even if CCSVI
may potentially induce EH through a pure
hydraulic mechanism CCSVI, per se does not
explain how the various disorders correlated
with MD may interact with CCSVI and provoke
EH. The aim of this review is an attempt to
approach MD into the context of the more
recent findings about the global brain waste
clearance system, to which inner ear is anatom-
ically and functionally connected, in order to
build a reasonable model of MD pathogenesis.
The major part of the diseases correlated to MD
may act on the inner ear disturbing the glym-
phatic (GS) and/or brain lymphatic system
(BLS) activity. The venous system interplays
with GS and BLS. In this model CCSVI is consid-
ered more than a direct cause of MD rather the
anatomical predisposition to develop the dis-
ease. In this model EH, and then MD, is the con-
sequence of a failure of the compensation of the
congenital venous abnormalities, anatomical
compensation as collateral pathways and/or
functional compensation as GS and BLS. In this
model the major part of the disturbances corre-
lated to MD and the various treatment proposed
find their appropriate placement.
Introduction
Ménière’s disease (MD) is a chronic illness
of the inner ear that affects a substantial num-
ber of patients every year worldwide. In Europe
the incidence is about 50-200/100,000 a year.1
The disease is characterized by intermittent
episodes of vertigo lasting from minutes to
hours, with sensorineural, usually fluctuating,
hearing loss, tinnitus, and aural pressure.
Attacks of vertigo may come on suddenly or
after a short period of tinnitus or muffled hear-
ing. Inner ear diseases, including MD, are usu-
ally considered as peripheral diseases but, espe-
cially for the reasons that this paper concern, it
is necessary to highlight at least three aspects
that oblige the clinicians, at least under the
therapeutic point of view, to approach the inner
ear as a central organ: inner ear structures are
deeply embedded into the petrous part of the
temporal bone, the unique ivory bony part of
the skull: i) inner ear vascularization is provid-
ed by a long slender branch of the anterior infe-
rior cerebellar artery (>85% cases) or basilar
artery (<15% cases) through the labyrinthine
artery (also named auditory artery or internal
auditory artery), that accompanies the vestibu-
lo-cochlear nerve through the internal acoustic
meatus; ii) inner ear drainage is formed by the
labyrinthine veins that accompany the branch-
es of auditory artery from the vestibule and
semicircular canals via the inferior petrous
sinus into the internal jugular veins (IJVs). MD
may be classified according to the worldwide
still accepted guide-lines published in 1995 by
the Committee on Hearing and Equilibrium of
the American Academy of Otology - Head and
Neck Surgery, into different grades of certainty
(Table 1).2
Because of a dearth of well-controlled stud-
ies, the medical and surgical management of
MD remains quite empirical. The main reason
is that it is very difficult to investigate patients
affected with certain MD due to the post-
mortem criterion necessary for this diagnostic
grade. Therefore every research is substantial-
ly conducted on patients with a lower diagnos-
tic grade due to the impossibility to conduct
control studies on certain MD. Every research
on MD is thus conditioned by this bias. For this
reason, in our opinion, every research sub-
stantially has to be considered as a high level
speculation with a reasonable certainty grade.
The aim of this paper is an attempt to
approach MD into the context of the more
recent findings about the global brain waste
clearance system to which inner ear is anatom-
ically and functionally connected in order to
build a reasonable model of MD pathogenesis.
Ménière disease and chroniccerebrospinal venousinsufficiency
MD is substantially characterized by three
symptoms, vertigo, hearing loss and tinnitus, it
is generally correlated to a lot of causes and it
is sustained by only one worldwide accepted
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hydraulic pathogenetic mechanism: the
endolymphatic hydrops (EH). Paparella3 used
the notion of lake-river-pond to explain the
occurrence of malabsorption of endolymph
leading to hydrops. This notion describes the
endolymphatic sac (ES) as a pond, with the
vestibular aqueduct (the river) connecting it to
the endolymphatic fluid space that is like a
lake. When there is an obstruction near the ES
or duct, a backlog of endolymphatic fluid is cre-
ated, leading to hydrops. The causes of this
kind of malabsorption of endolymph leading to
hydrops are still debated. 
At the beginning of our personal experi-
ences on chronic cerebrospinal venous insuffi-
ciency (CCSVI) we observed, quite incidental-
ly, a possible correlation between CCSVI and
inner ear disorders.4 In fact, comparing echo-
color Doppler (ECD) findings in multiple scle-
rosis (MS) and in a controlled group of
patients affected with different disorders we
found only three controls out of sixty showing
venous flow abnormalities: all of them had
been affected by sudden hearing loss. Thus, we
begun to extensively investigate CCSVI in a
large sample of subjects affected with audio-
vestibular disorders, including MD. 
In 2013 Alpini and colleagues described a
patient affected with5 bilateral CCSVI and
bilateral sudden sensorineural hearing loss
(SSHL). In 2013 Alpini and colleagues6 com-
pared ECD arterial and venous tests in
patients affected with cochleo-vestibular dis-
turbances subdivided into three groups: defi-
nite unilateral MD, non-MD cochleo-vestibular
impairment and patients affected with benign
paroxysmal positioning vertigo with cochlear
hearing loss. This paper showed that asymmet-
rical venous flow was more frequent in MD
patients than in others. Successively Di
Berardino and colleagues7 investigated CCSVI
in MD using both ECD and magnetic reso-
nance imaging (MRI) confirming the high cor-
relation between CCSVI and MD. This correla-
tion is further supported by Filipo and col-
leagues.8 Bruno and colleagues9 performed
percutaneous transluminal angioplasty (PTA)
in 20 MD CCSVI-positive patients obtaining at
six-months follow-up significant improvement
of symptoms (hearing loss and acute vertigo
spells) in 19. In 2015 Bavera and colleagues
presented at the 5th ISNVD Annual Meeting in
Naples a comparison of CCSVI characteristics
into three groups of patients: MD, MS and
other non-MD cochleo-vestibular disturbances.
Incidence of CCSVI in MD and MS was, as
expected, high, according to previous litera-
ture findings.10 Comparing CCSVI findings in
MS vsMD, the Authors showed that the level of
venous abnormalities was different: J1 in MS
and J3 in MD (Figure 1). 
Venous alterations are differently distributed
according to the kind of disease. Distribution is
expressed in % of abnormal examinations. J3I
is the most involved level in MD (27 definite
Ménière patients); J1 is the most involved level
in MS (70 clinically definite patients); in the
group other vestibular disorders (51 patients)
venous alterations are rare but J3 is still the
most represented level. This figure has been
redrawn from that presented by Bavera and col-
leagues at the 5th ISNVD Meeting.
Also Filipo and colleagues8 observed that MD
patients showed the prevalence of proximal
venous abnormalities with 76% of unidirec-
tional venous return in the petrosal sinuses.
Petrosal sinuses are directly involved in the
drainage of the inner ear.
In 2016 Vannini and colleagues at the 6th
ISNVD Meeting11 presented a comparison
between SSHL and MD patients regarding
presence and characteristics of IJVs valves
showing substantial differences in the two
groups confirming, in this way, a certain dis-
ease-specificity of CCSVI.
Hence, it seems nowadays reasonable to
state that CCSVI may be the anatomical back-
ground to develop EH in MD, at least in defi-
nite and probable MD patients. 
Model of brain circulationin chronic cerebrospinalvenous insufficiency andits correlation with Ménièredisease
The mechanism leading from CCSVI to MD
is still debated. Both Di Berardino and col-
leagues7 and Filipo and colleagues8 proposed a
hydraulic disorder, or venous vasculitis or the
microangiopathic changes usually associated
with chronic venous insufficiency. 
The blood-labyrinth barrier is impaired in
association with the EH.12 The luminal com-
partment of the inner ear, the endolymphatic
space, is separated by the abluminal compart-
ment, the perilymphatic space, by highly spe-
cialized epithelial cells with tight junctions.
The endolymphatic space contains luminal
fluid with high potassium (K+) concentration
and low sodium (Na+) concentration, which
provides the ionic milieu needed to sustain
transduction of sound and head acceleration
into VIII cranial nerve impulses. The fluid vol-
ume within the bony labyrinth remains con-
stant. Changes in the volumes of the endolym-
phatic and perilymphatic compartments are
responses to osmotic gradients between the
compartments themselves.13 Perilymph is con-
nected fairly directly to spinal fluid pathways
via the cochlear canaliculus. When spinal fluid
pressure changes, perilymph pressure changes
within about 10 s. The composition of
endolymph is maintained by stria vascularis,
that is the seat of K+ secretion. Stria vascularis
Table 1. The worldwide accepted and used diagnostic Ménière disease guidelines. It is interesting to highlight that the grade of certainty
is established to be possible only with post mortem confirmation.
The American Academy of Otolaryngology - Head and Neck Surgery Criteria for diagnosis of Ménière’s disease
The definition of the disease requires the combination of
1.       Recurrent spontaneous and episodic vertigo. A definitive spell of vertigo lasting at least 20 min, often prostrating, accompanied by disequilibrium that
          can last several days; usually nausea or vomiting, or both; no loss of consciousness. Horizontal rotatory nystagmus is always present
2.       Hearing loss (not necessarily fluctuating)
3.       Either aural fullness or tinnitus, or both
The classification of the disease is graded as follows
Certain Ménière’s disease                                                                                              Definite disease plus post mortem confirmation
Definite Ménière’s disease                                                                                            Two or more definitive episodes of vertigo plus audiometrically confirmed 
                                                                                                                                              sensorineural hearing loss, plus tinnitus, aural fullness, or both
Probable Ménière’s disease                                                                                           One definitive episode of vertigo plus audiometrically confirmed sensorineural 
                                                                                                                                              hearing loss plus tinnitus, aural fullness, or both; other causes excluded
Possible Ménière’s disease                                                                                            Episodes of vertigo with no associated hearing loss or hearing loss with 
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is densely vascularized compared with the
avascular Reissner’s membrane and single-
vessel metabolic supply of the Outer Sulcus.
Reissner’s membrane is thought to be primari-
ly responsible for Na+ homeostasis of cochlear
endolymph. Outer Sulcus epithelium is located
in the lateral cochlear wall, it is capable of
absorbing Na+ and provides a parasensory
shunt for K+ efflux.14 Endolymph is coupled
more indirectly to cerebrospinal fluid (CSF)
pressure and air pressure, through mem-
branes. One pathway is via the endolymphatic
duct, to the sac, and the dural membrane.
Another is via the membranes that separate
the endolymphatic and perilymphatic compart-
ments. Normally, there is little flow of
endolymph either radially or longitudinally. If
endolymphatic volume becomes excessive it is
reabsorbed back into the stria vascularis by
means of radial flow. When there is a largest
volume increase endolymph move longitudi-
nally into the ES. The ES is a blind pouch, its
epithelial cells consist primarily of two types:
mitochondria-rich cells and ribosome-rich
cells but little is known about the ion transport
properties of each cell type. ES is placed on the
posterior surface of the petrous portion of the
temporal bone, where it is in contact with the
dura mater and perform both absorptive and
secretory, as well as phagocytic and immun-
odefensive, functions.
In this way the underlying mechanism of EH
is still debated, with some researches in favor
of a purely hydraulic mechanism and others
hypothesizing a control mechanism of ionic
balance. Hydraulic hypothesis supports ES sur-
gery, while control hypothesis pharmacologic
treatments. 
On the other hand, several studies analyzing
the temporal bone anatomy in MD patients
have found consistent alterations in the
arrangement of the sigmoid sinus, anteriorly
or medially displaced, and jugular bulb abnor-
malities (JBA).15 For these reason sac-vein
decompression16 seems to be more effective
that sac decompression alone. 
If the role of intracranial veins in causing
abnormalities of inner ear metabolism and then
labyrinth function is easy to understand, more
difficult is to correlate alterations of neck vein
structures on cerebral venous hemodynamics. 
Müller and Toro17 described a mathematical
model for the cardiovascular system in order to
describe the complex interaction between
intracranial pressure and cerebral vasculature
and the Starling-resistor like behavior of the
intracranial veins. 
The cranial cavity is a space of fixed volume
containing parenchyma, the brain, and fluids,
CSF and blood, fluids functionally connected:
variations in intracranial blood volume pro-
duce fluctuations of intracranial pressure and,
consequently, exchange of CSF between the
intracranial and spinal subarachnoid spaces.
In this way18 blood volume may regulate
glimphatic system.19 Furthermore, variations
in intracranial blood volume20 may potentially
influence on brain lymphatic system.21
Intracranial veins are flexible tubes that
drain into the various dural sinuses, located in
the dura madre and therefore more rigid than
cerebral veins.
Starling resistor is a an experimental device
in which a collapsible tube, like an intracranial
vein or IJV, is connected to two rigid tubes, like
the dural sinuses, at its extremities and locat-
ed in a chamber of fixed volume with variable
ambient pressure, like the cranial cavity. 
The pressure difference that regulate cere-
bral blood flow (CBF) both to feed brain
parechima and to drain waste products of the
brain parenchima metabolism, is depending
on the difference between arterial and
intracranial pressure, so called cerebral perfu-
sion pressure. CBF is considered as a flow phe-
nomenon governed by a Sterling resistor.18
CSF filtration from the subarchnoid space
towards the dural sinuses varies linearly with
the difference between intracranial pressure
and superior sagittal sinus pressure. 
The model proposed by the Authors indi-
cates that the leading mechanism of Starling-
resistor like behavior of intracranial veins is at
the point where they join dural sinuses. 
Structural, like JBA, or functional, like in
CCSVI, abnormalities of the cervico-cephalic
veins may impair drainage of the inferior pet-
rosal sinuses through increased pressure or
blood reflux into the sinuses.8 In this way,
labyrinth drainage into the petrosal sinuses
through endolymphatic radial flow, by means
of the cochlear and the vestibular aqueduct
veins, and longitudinal flow, by means of ES, is
impaired. These phenomena increase inner
ear pressure, leading to EH, and/or induce
alteration in K+/Na+ balance in the inner ear
fluids, provoking MD attacks.
Furthermore, since many of the venous ves-
sels in the scala tympani have little or no bony
covering and are essentially exposed to the
perilymphatic space,22 the venous system cold
become a route of entry for the cells participat-
ing in the inner ear inflammatory process
especially if slowing or refluxing of venous
flow as observed in CCSVI, prolong the persist-
ence of toxins, autoantibodies or pathogens
into the inner ear like viruses23-25 free radicals26
and cochlear autoantibodies, like HSP 70.27
MD has been correlated also to migraine28,29
but CCSVI has been described also in chronic
migraine patients.30 Since, generally speaking,
venous flow may be depending also on global
circulating blood volume, it is possible that
hyperidric diet31 frequently proposed to MD
patients, may act directly facilitating brain-
inner ear venous drainage. 
Some aspects of MD may be explained also
without considering CCSVI. For example,
lifestyle changes and hypertension32 treatment,
including salt restriction,33 one of the most
popular treatment regimen in MD and contin-
uous positive airway pressure in obstructive
Figure 1. Distribution of levels of detected venous abnormalities
in three groups of patients. MD, Ménière disease; MS, multiple
sclerosis; OVD, other vestibular disorders.
Figure 2. Distribution of side of Ménière disease (MD) in relation
with gender.
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sleep apnea syndrome (OSAS),34 may act
directly on inner ear vascularization35 and
therefore on endolymph production, frank
hypoglycemia36 and hyperinsulinemia, rather
than diabetes,37-39 it is known to alter Na+/K+
inner ear pump, the same pump on which is
supposed acts proton pump inhibitors.40
Since MD has been correlated mostly to a
wide and different diseases and treatments in
addition to those mentioned above,41 CCSVI
may be considered more than a cause of MD
per se, rather the anatomical predisposition to
develop the disease. 
The role of IJVs in MD has been extensively
investigated and IJVs abnormalities are sub-
stantially considered the main alteration that
may condition the onset of the disease. On the
other hand, IJV it is known to be main route of
venous drainage when supine. The extracra-
nial venous circulation is strongly influenced
by posture as demonstrated by Gadda and col-
leagues42 that correlated, in a simulated model,
the cross-sectional area and the perimeter of
joint vibration analysis during the cardiac
cycle. Authors showed that IJV is completely
distended in supine position and collapsed
when standing. In both postures vertebral
veins drain the brain, in general, and, particu-
larly, the brainstem and the cerebellum. 
A retrospective review of MRI performed in
the MD patients that we studied for the previ-
ous paper on CCSVI in MD,6,7,10 showed com-
pensatory hypertrophy of vertebral plexus or
vertebral veins or both in all the patients that
presented IJVs abnormalities.
The complex connection between the inner
ear and the neck43 support the idea that a dis-
turbed labyrinth leads to a disturbance of head-
to-neck position control and neck function
increasing drainage difficulties through deep
cervical muscles compression of the vertebral
plexus. Furthermore, the idea that IJVs do not
compensate primarily impaired vertebral
drainage dysfunction had to be taken in account.
Mülle and Toro observed17 flow distribution
asymmetry between right and left transverse
sinuses and, consequently, between left and
right IJV. It is interesting to note that Simka
and colleagues44 showed that in MS venous
malformations were more commonly found on
the left side. The prevalence of left internal
jugular vein malformations was 81.7% vs
64.0% on the right side. Similarly, blockages
were found only in the left and not in the right
brachiocephalic vein. Same findings in MS
have been recently reported by Bavera.45
Herman,46 in 1993 reported predominance of
left ear in MD, sudden deafness, and inner ear
damage. Successively, in 2014 Reiss and
Reiss47 confirmed the prevalence of left SSHL
at least in females. 
We conducted a retrospective evaluation of
135 patients (mean age 43±6 years) affected
with definite unilateral MD. MD affected the
right side in 57 and the left side in 78 with the
slight left expected prevalence (57%). But,
right MD regarded 29 females (51%) while left
MD regarded only 17 males with a prevalence
of 78% of females (Figure 2). In our experi-
ence the correlation between the MD side and
prevalent venous abnormalities side is 87%.
Therefore, our experience confirms the left
prevalence either of CCSVI or MD. CCSVI is
considered to be a congenital venous malfor-
mation. In adults, the IJVs that drain the brain
develops from precardinal veins in the
embryo.48 These precardinal veins mostly join
the common cardinal veins, in the area where,
in an adult, the jugular valve is found. As stated
by Simka and colleagues44 it is plausible to
imagine that this process could not always be
perfect, especially on the left side, where part
of the left common cardinal vein naturally
involutes. Even the left prevalence is not so
high as in MS this fact is at least intriguing. 
Left MD present a slight prevalence (57%)
but it is to highlight that the distribution of
females is highly prevalent in left MD while in
right MD genders are equally represented. 
However, despite the side, MD has been cor-
related to a very wide range of very different dis-
orders: herpetic neuropathy,25 autoimmune not
cochlear pathologies,49,50 metabolic disorders,37
sleep disorders,51water/salt imbalance,52 cervical
disorders,53 allergies54 and food intolerance with
special regard to gluten sensitivity.55,56
Subject to the foregoing, it is our opinion
that there is a gap between the so wide and so
different disturbances connected to MD and a
unique specific pathogenetic mechanism
(EH). The stagnation per se due to jugular
stenosis and/or intratemporal reflux or persist-
ence of pathogens into the inner ear veins pre-
cisely due to venous stagnation does not
seems to us enough.
Bearing in mind the venous cervico-cephal-
ic drainage system into the context of the most
complex waste brain clearance apparatus, con-
stituted also by the glymphatic and the lym-
phatic systems, may bridge this gap. 
Ménière disease, chroniccerebrospinal venousinsufficiency and glymphaticsystem
The veins of the vestibule and semicircular
canals accompany the arteries, and, receiving
those of the cochlea at the base of the modio-
lus, join to form the internal auditory veins (or
veins of labyrinth) which end in the posterior
part of the superior petrosal sinus or in the
transverse sinus. The common modiolar vein
enters the bony channel immediately adjacent
to the aqueduct to become the vein of the
cochlear aqueduct, which in turn drains via the
inferior petrous sinus into the IJVs. The
cochlear aqueduct and the internal auditory
canal communicate with the subarachnoid
space57 from where the CSF is driven into the
Virchow-Robin spaces by a combination of arte-
rial pulsatility, respiration, slow vasomotion
and CSF pressure gradients.58 The forces that
drives CSF towards brain parenchyma are the
same that regulates venous cervico-cephalic
drainage.59 As it is known, the clearance system
that utilizes perivascular tunnels formed by
astroglial cells is the glymphatic system (GS).19
Consequently, due to the anatomy of its
structures, the inner ear is therefore connect-
ed both to the cervico-cephalic venous system
and the GS. The GS also facilitates brain-wide
distribution of glucose, amino acids, lipids and
neuromodulators.60 In the same way, through
the internal auditory canal, the same sub-
stance may reach the perilymphatic space.
Acetazolamide, an inhibitor of carbonic anhy-
drases, is widely used in the treatment of MD61
to reduce EH. However, acetazolamide is
known to have a strong effect in reducing CSF
formation. We think that the connection
between inner ear and GS may explain the
therapeutic effects of acetazolamide in MD:
the reduction of CSF may induce a retrieval of
perilymph reducing inner ear pressure.
The CSF movement into the parenchyma
drives convective interstitial fluid fluxes with-
in the tissue towards the perivenous spaces
surrounding the large deep veins. The intersti-
tial fluid is collected in the perivenous space
from where it drains out of the brain towards
the cervical lymphatic system. 
GS functions mainly during sleep and it is
largely disengaged during wakefulness.62
Nakayama and colleagues51 found in 35 definite
MD that total sleeping time was significantly
higher than in controls. Nevertheless, they also
showed, for the first time, a poor quality of
sleep with decreased deep sleep and an elevat-
ed arousal index. Yet, major sleep disorders like
OSAS were rare and not MD specific: 4 cases in
MD group and 3 in controls. Hence, it is unlike-
ly that MD is due to reduced brain oxygenation
or vascular disturbances as observed in OSAS,
while, in our opinion, these data support the
role of a GS disturbance in MD pathogenesis, at
least in patients affected with a poor quality of
sleep. In the same way the role of stress, that is
considered as a trigger of MD attacks,63,64 may
be interpreted: stress increase brain levels of
norepinephrine that is known to be responsible
for suppression of GS.65
The supposed GS disturbance may not to be,
for example, the reactive gliosis of aging
because there is an inverse correlation
between age and MD prevalence:66 MD typically
starts between the ages of 20 and 50. In addi-
tion, MD is not a neurodegenerative disease.
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unlikely to be linked to glia and astrocytes. It is
more reasonable the involvement of the aqua-
porins (AQP): they regulate the production both
of CSF and endolymph. AQP are  membrane
proteins also known as water channels that
form pores in the membrane of biological cells.
AQP selectively conduct water molecules in and
out of the cell, while preventing the passage of
ions and other solutes. Some of them, known as
aquaglyceroporins, also transport across the
membrane other small-uncharged solutes, such
as urea, CO2, ammonia and glycerol, depending
on the size of the pore. The so-called glycerol
test (GT) is a still worldwide employed test for
the diagnosis of MD.67 Ingestion of glycerol, 1.5
g/kg body weight, causes a transient reduction
of the hearing loss in the early stage of MD. In
some cases improvements occur with consider-
able speech discrimination gain. No glycerol
effect is seen in normal or cases of cochlear
deafness of other types. The GT has been
recently re-visited using the vestibular evoked
potentials68 instead of the Pure Tone
Audiometry in order to have a more objective
test. The action of glycerol is purely osmotic and
the effect in MD is due to a reduction of intral-
abyrinthine pressure by means of specific AQP.
It is interesting to note though, that AQP1 is
expressed both in the choroid plexuses, that
produce CSF, and in the stria vascularis of
cochlea, that produce endolymph69 in the rats.
In humans AQP1 is localized to fibrocytes and
blood vessels of the underlying stroma and tra-
becular perilymphatic tissue:70 venous vessels
are connected to the perilymphatic space, thus
it is more probable that glycerol acts on
endolynphatic pressure through the functional
connections between venous system and GS
than directly on inner ear.
In hypertension, another putative cause of
MD32 vasopressine dysregulation71 may be
claimed and the anti-diuretic hormone results
to be involved both in GS72 and in EH.73
In conclusion, we can state that a defective
venous system as in CCSVI interferes with regu-
lar function of GS. When another factor of GS
dysfunction occurs, like stress or hypertension or
sleep/awakness cycle dysregulation, inner ear
may become unable to clear waste products of its
metabolism either through the subarachnoid
space and GS and the river-lake-pond system
blocks leading to the endolymphatic hydrops.
Ménière disease, chroniccerebrospinal venousinsufficiency and lymphaticsystem
A true lymphatic vascular system (LS) drain-
ing brain interstitial fluids and macromole-
cules has been very recently described.21,74
Generally speaking, LS is constituted by a net-
work of lymphatic vessels in the dura mater of
the CNS that drains out of the skull via the
foramina of the base of the skull itself along-
side arteries (the major branches of the mid-
dle and anterior meningeal arteries and the
pterygopalatine artery), cranial nerves (I, V, IX,
X and XI) and veins. Lymphatic vessels have
been observed in the dural lining of the cribri-
form plate, where some vessels passe through
the skull into the nasal mucosa. 
Dura mater lymphatic vessels drains brain
ISF into deep cervical lymp nodes and experi-
ments conducted in mice60 showed that impair-
ment of LS compromises CNS macromolecule
clearance. As stated also by Zamboni75 the inter-
connection of brain lymphatics with both the
nasal mucosa and the deep cervical lymph-nodes
allows T-cells and viruses to easily circulate into
the brain and therefore in the inner ear too.
In MD either virus infections by Herpes
viruses76 or autoimmune viral activation77 or
autoimmune diseases as thyroiditis78 have
been considered as probable causes of the dis-
ease. The lymphatic vessels run down toward
the base of the skull along the transverse sinus,
the sigmoid sinus, the retrosigmoid vein and
the rostral rhinal vein. The ES, the pond into
Paparella’s model, is placed on the posterior
surface of the petrous portion of the temporal
bone, where is in contact with the dura mater.
The endolymphatic duct and ES perform
absorptive and secretory, as well as phagocytic
and immunodefensive functions: the ES is
capable of antigen recognition and processing
for initiation of an immune response.79,80
Reflux of venous blood flow into the petrous
veins, and, as a consequence along modiolar
veins, may alter the capability of the endolym-
phatic sac to drain via the lymphatic dura ves-
sels with an alteration of its immunocompe-
tence of the ES inducing recurrent flogistic EH
episodes.81
Another group of diseases claimed as MD
cause are allergies, in general, food allergies,
in particular. For almost a century inhalant and
food allergies have been linked with MD symp-
toms.82 The prevalence of allergy in patients
with MD is almost three times than in the gen-
eral population.83 Wheat is one of the most
common food allergens found in patients with
MD, 68.2% according to Derebery and col-
leagues.84 In 2010 Derebery and colleagues85
defined the relation between allergy and MD.
In 2012 Di Berardino and Cesarani55 confirmed
the relation between immune response to the
acid proteins fraction of gliadin in MD and in
2013 Di Berardino and colleagues56 reported
recovery of MD after gluten-free diet. 
Recently, Di Berardino and colleagues86 in a
group of 116 definite MD patients (52 male
49.5±12 years - 63 Female 49.8±13 years)
showed an incidence of 96% of atopic subjects
by means of an allergo-immunologic battery
including skin tests (prick test, prick by prick
and/or intradermo reaction) intestinal perme-
ability test and nasal mucociliary clearance
(NMC).87 In MD NMC was significantly slowed. 
It is well known the correlation between MD
and nose disorders, generally read as to be sus-
tained by Eustachian tube disturbances.88 In
our opinion, the correlation between nose and
EH pass through the LS: slowing of NMC in
atopic patients may lead to slowing of aller-
gens clearance in cervical lymphnodes and
therefore a sensitization of the inner ear that
become a hypersensitive target of the immune
response to antigens.89,90
Venous disturbances may hamper inner ear
lymphatic drainage through the perivenous
lymphatic vessels. The putative correlation
between cervico-cephalic venous regulation
and nasal function may be sustained because
the nose is not only a clearance organ but also
a sophisticated conditioning system of the
breathed air. It regulates both humidity and
temperature of the inhaled air in order to
maintain enough constant the physical charac-
teristics of the air that reach the lungs despite
the environmental conditions. This condition-
ing is due to the regulation of blood flow of the
like-erectile tissue contained into each
turbinate (three each side). As in corpus cav-
ernosum, swelling of turbinate depends on
arterial inflow and venous outflow. Congestion
of the nose is also linked to body position, to be
maximum on the side on which the subject is
lying, head angle with respect to the trunk
when supine, to be maximum when it is lower
than 20°, and eventual pressure exerted on
axillar vein with swelling of the same side.91
Lifting the head more than 20° when sleeping
on one hand facilitate nasal patency, on the
other hand, it is usually suggested to a patient
affected with CCSVI (so called inclined-bed-
therapy). Furthermore, Eustachian Tube exer-
cises using a small balloon to be inflate using
the nose is usually suggested in MD patients
in order to relieve aural fullness: this is noth-
ing but repeated Valsalva maneuver that de
facto facilitates venous drainage from the
brain to the thorax.
In conclusion, we can state that a defective
venous system as in CCSVI interferes with reg-
ular function of LS. When another factor of LS
dysfunction occurs, like virus infections or
allergic reactions or autoimmune diseases, ES
may become unable to clear throughout the
lymphatic vessels, the river-lake-pond system
blocks leading to the inflammatory EH.
Bridging the gap
The presence of venous disturbances in a
high percentage of patients affected with defi-
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malities seem to be disease specific due to the
specific anatomic11 and functional7,8 findings
observed. Furthermore, it seems that venous
disturbances are also and organ specific inter-
preting Bavera and colleagues10 experience
that, although the number of positive cases was
very low, found J3 as the most represented dys-
functional level also in non-MD vestibular dis-
eases. Obviously, this last observation needs to
be confirmed in a largest number of patients. 
This paper represents a putative model of
interpreting the effects of CCSVI on inner ear
under the light of brain GS and LF. From an
epistemological point of view, a theory is a
series of logical steps that are as valid as they
are true while a model, the form of presenta-
tion we have chosen, is a series of logical steps
as valid as useful. The helpfulness of our
model is to allocate the various disorders and
pathologies considered to be involved in MD in
a logic and unitary explanation and, conse-
quently, to facilitate therapeutic planning.
CCSVI may lead to endolymphatic hydrops
through a pure hydraulic mechanism and
therefore both an accurate case history and a
complete evaluation of the patient are neces-
sary in order to identify which compensatory
circuits have been blocked to cause failure of
compensation of the congenital abnormalities.
On the basis of the Literature we think that the
most probable blocked circuits in MD are the
vertebral plexus,92 the thyroid veins78 and the
anterior condylar confluent.93,94
Failure of compensation may regards also
the GS and/or the LS. Again, an accurate case
history and a complete evaluation of the
patient are necessary in order to identify why
GS and/or LS are not able to compensate the
venous clearance. 
On the basis of the literature we think that
the most probable causes of a blocked GS in
MD are sleep disorders, stress,95 nicotine95 and
excitants abuse96 water/salt balance dysregula-
tion,97 intestinal disorders.98
On the basis of the Literature we think that
the most probable causes of a blocked LS in
MD are virus infections,99 viral reactivations,100
activation of viral inner ear epitopes,101 sys-
temic autoimmune diseases,102 middle ear dis-
eases,103-105 allergies,106 nasal disturbances,107
food intolerances.108
In conclusion, MD therapy requires accurate
identification and treatment of each structural,
metabolic ear, nose, throat and general diseases
of the specific patient according to a model that
we can define as a glocal model of ménière dis-
ease. This glocal model suggest to subdivide MD
in two main groups: i) structural MD, in which
a structural JBA may directly act impairing
inner ear metabolism; ii) combined MD, in
which two out of three brain drainage systems
are impaired or compensatory venous pathways
are impaired in CCSVI-positive MD patients.
Considering that PTA induces immediately a
significant relief of symptoms in MS patients
but requires at least three months109 to obtain
hearing improvement and vertigo attacks
reduction in MD patients, further researches on
the correlation between CCSVI and MD had to
taken in account the possible causative role of
the vertebral veins per se on inner ear disorders.
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